Selected Podcast

Heartburn or Cancer? Recognizing the Signs

If you lie down after a big meal, you could bring on some nasty heartburn.

But what if it's something worse?

While uncommon in the U.S., esophageal cancer can be deadly. Most people don't notice anything wrong other than indigestion, and that's why it's important to know about your risk factors -- and prevention factors.

In this segment, esophageal cancer expert, Ronan Kelly, MD, will explain what this cancer is, who is at risk, and how it's treated.

Dr. Kelly is the head of Medical Oncology for the Johns Hopkins Esophageal Cancer Program, where he focuses on affordable, effective cancer care. He is also a board member with ECAN (Esophageal Cancer Action Network). You can visit the ECAN website at www.ECAN.org.

Bonus!
Not Satisfied in Bed? Your Partner Can Tell

Heartburn or Cancer? Recognizing the Signs
Featuring:
Ronan Kelly, MD
Dr. Ronan Kelly, MD, MBA, heads Medical Oncology for Esophageal Cancer at Johns Hopkins Medicine, as well as the Johns Hopkins International Oncology program. Dr. Kelly is a thoracic oncologist at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and is leading translational research efforts in esophageal, gastro-esophageal and gastric cancer.

His research involves utilizing epigenetic changes as biomarkers to better predict which chemotherapies patients should receive in both the operable and metastatic setting. In addition, he is evaluating novel targeted agents and is incorporating immunotherapeutic and epigenetic modifying agents in upper GI tumors.

Dr. Kelly chairs the Johns Hopkins esophageal and gastric cancer working groups and is a prominent member of the Eastern Cooperative Oncology Groups gastro-esophageal cancer task force. In addition to academic research in upper GI tumors, Dr. Kelly is actively involved in designing pathways and implementing strategic developments to decrease cancer costs while improving efficacy both nationally and internationally. He is an ECAN (Esophageal Cancer Action Network) board member and he just authored an interesting study on ways to cut costs in cancer treatment without hurting patient care.